Stop antibiotics when you feel better? Opportunities, challenges and research directions.


Journal

JAC-antimicrobial resistance
ISSN: 2632-1823
Titre abrégé: JAC Antimicrob Resist
Pays: England
ID NLM: 101765283

Informations de publication

Date de publication:
Oct 2024
Historique:
medline: 10 9 2024
pubmed: 10 9 2024
entrez: 10 9 2024
Statut: epublish

Résumé

Shortening standard antibiotic courses and stopping antibiotics when patients feel better are two ways to reduce exposure to antibiotics in the community, and decrease the risks of antimicrobial resistance and antibiotic side effects. While evidence shows that shorter antibiotic treatments are non-inferior to longer ones for infections that benefit from antibiotics, shorter courses still represent average treatment durations that might be suboptimal for some. In contrast, stopping antibiotics based on improvement or resolution of symptoms might help personalize antibiotic treatment to individual patients and help reduce unnecessary exposure. Yet, many challenges need addressing before we can consider this approach evidence-based and implement it in practice. In this viewpoint article, we set out the main evidence gaps and avenues for future research.

Identifiants

pubmed: 39253334
doi: 10.1093/jacamr/dlae147
pii: dlae147
pmc: PMC11382136
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

dlae147

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.

Auteurs

A J Borek (AJ)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
National Institute for Health and Care Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK.

A Ledda (A)

National Institute for Health and Care Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK.
Clinical and Public Health, UK Health Security Agency, London, UK.

K B Pouwels (KB)

National Institute for Health and Care Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK.
Nuffield Department of Population Health, University of Oxford, Oxford, UK.

C C Butler (CC)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
National Institute for Health and Care Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK.

G Hayward (G)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

A S Walker (AS)

National Institute for Health and Care Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK.
Nuffield Department of Medicine, University of Oxford, Oxford, UK.
NIHR Biomedical Research Centre, Oxford, UK.

J V Robotham (JV)

National Institute for Health and Care Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK.
Clinical and Public Health, UK Health Security Agency, London, UK.

S Tonkin-Crine (S)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
National Institute for Health and Care Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK.

Classifications MeSH